An epitope-specific chemically defined nanoparticle vaccine for respiratory syncytial virus

Respiratory syncytial virus (RSV) can cause severe respiratory disease in humans, particularly in infants and the elderly. However, attempts to develop a safe and effective vaccine have so far been unsuccessful. Atomic-level structures of epitopes targeted by RSV-neutralizing antibodies are now know...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuniga, Armando, Rassek, Oliver, Vrohlings, Melissa, Marrero-Nodarse, Aniebrys, Moehle, Kerstin, Robinson, John A., Ghasparian, Arin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213762/
https://www.ncbi.nlm.nih.gov/pubmed/34145291
http://dx.doi.org/10.1038/s41541-021-00347-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213762/
https://www.ncbi.nlm.nih.gov/pubmed/34145291
http://dx.doi.org/10.1038/s41541-021-00347-y

Ejemplares similares